1143P Effect of best response to first-line (1L) treatment (tx) on outcomes with second-line (2L) nintedanib (NIN) + docetaxel (DOC) for patients (pts) with lung adenocarcinoma after 1L immune checkpoint inhibitor (ICI) combination therapy

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 33; pp. S1072 - S1073
Main Authors	Grohé, C., Wehler, T.C., Henschke, S., Dittrich, I., Hammerschmidt, S., Aulmann, C., Dechow, T.N., Schiefer, C., von der Heyde, E., Schuette, W., Atz, J., Kaiser, R.
Format	Journal Article
Language	English
Published	01.09.2022
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2022.07.1267